Tag: Protein
Agilus Diagnostics launches Anti-MCV antibody test in collaboration with Sebia to...
The test detects autoantibodies against a mutated form of the vimentin protein, commonly found in the synovial fluid of RA patients
Loopworm raises $3.25M Pre-Series A to commercialize breakthrough recombinant protein production...
Advanced silkworm bio-factory set to disrupt protein production systems through its novel technology
Aurigene’s Dr. Gayathri Ramaswamy showcases exciting data on rapid design &...
Dr Ramaswamy's presentation highlighted the potential of these molecules to accelerate drug discovery by enabling targeted protein degradation with enhanced specificity and efficiency
India’s indigenous medtech innovation, FIBROPLUG proves its mettle in emergency battlefield...
The country's first patented silk-chitosan composite hemostatic sponge was jointly developed by Fibroheal Woundcare an innovative Indian medtech startup and the Indian Institute of Science, Bengaluru
Avaana Capital leads ₹32 crore investment in GreenGrahi to build &...
Largest investment in India’s insect-based protein and agri-biotech sector to date
“We are on the brink of transformative era in nutrition and...
In an exclusive interview, Ankit Alok Bagaria, Co- Founder, Loopworm shares insights on his company’s focus on turning insects into a powerful bioresource
Sterling Biotech to start world’s first precision fermentation-based dairy protein factory...
Spanning 27 acres, this state-of-the-art facility is expected to be operational by the first quarter of 2026
Loopworm secures prestigious EU TRACES certification for silkworm pupae-derived products, opens...
This milestone positions Loopworm, which operates a GMP+, ISO 22000, and HACCP-certified facility with a 6,000 metric tonnes per annum capacity, as a key player in the EU market for sustainable protein sources
Loopworm secures ISO 22000, GMP+ and HACCP certifications
These certificates help Loopworm establish itself as a reliable company in the supply of pet food and animal feed products in global markets
FACE TO FACE: Dr Prabuddha Kundu, Managing Director, Premas Biotech
Dr Prabuddha Kundu, Co-founder & Managing Director, Premas Biotech recently on the sidelines of Global Bio India 2024 in New Delhi shared his insights on his company focus on global collaborations, industry's key growth drivers, India's US$ 300 billion bioeconomy target by 2030 and much more.